A Registered Cohort Study on Charcot-Marie-Tooth Disease
NCT ID: NCT04010188
Last Updated: 2022-01-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
500 participants
OBSERVATIONAL
2019-07-01
2049-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Muscle MRI in Charcot Mary Tooth Disease: a Prospective Cohort Study
NCT03550300
Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others
NCT01193075
Gut Microbiota in Patients With Moyamoya Disease
NCT04890782
Development and Validation of a Disability Severity Index for CMT
NCT01455623
Identification of Novel Biomarkers in Early Charcot-Marie-Tooth 1A Disease
NCT07049588
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Genetic diagnosis of patients with Charcot-Marie-Tooth disease
* Unrelated healthy controls
Exclusion Criteria
* Other peripheral neuropathy caused by trauma, immunity and toxicosis.
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ning Wang, MD., PhD.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ning Wang, MD., PhD.
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
First Affiliated Hospital of Fujian Medical University
Fuzhou, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MRCTA,ECFAH of FMU [2019] 192
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.